Moderna is leveraging its mRNA platform to expand beyond COVID-19 vaccines into RSV and oncology therapeutics. Vertex Pharmaceuticals maintains market dominance in cystic fibrosis while successfully ...
Vertex faced downward price pressure from biotech sector weakness and technical selling.Core fundamentals remain supported by ...
UCLA Health researchers have designed an algorithm to help doctors choose which of two new medicines to use when treating a ...
The former general manager of Marblehead’s Warwick Theater is publicly accusing the movie house’s ownership group of failing to pay employees, movie studios and vendors despite bringing in more than ...
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, ...
Quince Therapeutics, Inc. announced that Leone Patterson, age 63, Ms. Patterson served as Executive Vice President, Chief Business Officer and Chief Financial Officer of Zymeworks, Inc. from September ...
For the final 10% of cystic fibrosis patients who cannot benefit from breakthrough drugs, Emily's Entourage is funding ...
Previously disclosed post hoc PreciSION CF analyses of SION-719 support advancement of SION-451 + SION-2222 into the AscenSION CF Phase 2a ...
Andrew Hill Investment Advisors recently released its third-quarter 2026 investor letter. A copy of the letter can be ...
"Epicore and MECFA partner on wearable cystic fibrosis test" was originally created and published by Medical Device Network, a GlobalData owned brand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results